The IRDiRC Interdisciplinary Scientific Committee (ISC) works on cross-cutting aspects of rare disease research, including data sharing, ontologies, natural history, biobanking and registries. The ISC works closely with the Diagnostics and Therapies Scientific Committees to develop bridging aspects and standards, and plays a key role in promoting the IRDiRC Recognized Resources.
The ISC has been instrumental in developing and supervising the Task Force aimed at enabling automatable consent-based data discovery and access. The ISC also developed a guiding policy in the generation of privacy-preserving identifiers for research participants across multiple projects, and model consent clauses for rare disease research.
In advancing towards the 2027 IRDiRC goals, the key actions of the ISC in the short term are:
- Developing recommendations on guiding principles for national/trans-national policies for clinical research networks within an international context to enable collaboration and interoperability
- Facilitating the conduct of natural history studies relating to rare diseases
| Name | Title and Organization | |
|---|---|---|
 | Gareth Baynam (Chair) | Medical Director at Rare Care Centre, Perth Children’s Hospital, Australia |
 | Marc Dooms (Vice-Chair) | Center for Clinical Pharmacology, University Hospitals Leuven, Belgium |
 | Chiu-Hui Mary Wang | Global Programme Director at Rare Diseases International (RDI), Italy |
 | Chun-Hung Chan | Director at Sanford Biobank, USA |
 | Claudia Gonzaga-Jauregui | Assistant Professor at Universidad Nacional Autónoma de México, Mexico |
 | Claudio Carta | Researcher, National Centre for Rare Diseases, Istituto Superiore di Sanità, Italy |
 | Elmira Safarova | Founder and CEO Rarus Health SPA, Chile |
 | Helen Malherbe | Director of Research and Epidemiology at Rare Diseases South Africa NPC, South Africa |
 | Kate Baker | MRC Cognition and Brain Sciences Unit, University of Cambridge, UK |
 | Kazuko Wada | M.D., Director, Department of Neonatal Medicine, Osaka Women's and Children's Hospital, Japan |
 | Lindsey Murray | Executive Director at Critical Path Institute (C-Path), USA |
 | María del Mar Mañú Pereira | Head of the Rare Anemia Disorders Research Laboratory, Vall d'Hebron Institut de Recerca & Hospital Universitari Vall d’Hebrón, Spain |
 | Ritu Jain | Founder DEBRA International, Singapore |
 | Takeya Adachi | Research Assistant Professor at the Kyoto Prefectural University of Medicine, Japan |
 | Robert Allaway | Principal Scientist, Sage Bionetworks, USA |
Related link :